Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To investigate the impact of antihypertensive therapy with the selective mineralocorticoid
receptor blocker, eplerenone, on small resistance artery remodeling, compared to the effect
of equivalent blood pressure control achieved with a b-blocker, atenolol.